Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * KLEIN KENNETH JOSEPH	2. Date of Event Requiring Statement (MM/DD/YYYY) 10/1/2018	3. Issuer Name and Ticker or Trading Symbol Nobilis Health Corp. [HLTH]
(Last)        (First)        (Middle) 11700 KATY FREEWAY, SUITE 300	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                            _____ 10% Owner ___ X ___ Officer (give title below)          _____ Other (specify below) See Remarks /
(Street) HOUSTON, TX 77079        (City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5000	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	7/6/2015   (1)	7/6/2025	Common Stock	150000	$6.29   (2)	D
Stock Options (Right to Buy)	9/22/2016   (3)	9/22/2025	Common Stock	150000	$4.57   (4)	D
Stock Options (Right to Buy)	3/31/2016   (5)	1/29/2026	Common Stock	150000	$1.97   (6)	D
Stock Options (Right to Buy)	3/31/2018   (7)	12/31/2027	Common Stock	50000	$1.40   (8)	D
Stock Options (Right to Buy)	(9)	9/13/2028	Common Stock	100000	$0.84   (10)	D
Restricted Stock Units	9/13/2021	(11)	Common Stock	48000	(12)	D

Explanation of Responses:
(1)	The options vested as to 50,000 on May 1, 2016, 50,000 on May 1, 2017 and 50,000 on May 1, 2018.
(2)	Stock Options granted at C$7.94. Conversion rate at July 6, 2015 was 0.7920 [1.2626], based on the Bank of Canada noon rate.
(3)	The options vested as to 50,000 on 9/22/2016, 50,000 on 9/22/2017 and 50,000 on 9/22/2018.
(4)	Stock Options granted at C$6.07. Conversion rate at 9/22/2015 was 0.7531 [1.327] based on the Bank of Canada noon rate.
(5)	Vest ratably on calendar quarterly basis beginning on 3/31/2016 until final vesting date of 12/31/18.
(6)	Stock Options granted at C$2.78. Conversion rate at 1/29/2016 was .7102 [1.4080] based on the Bank of Canada noon rate.
(7)	Vest ratably on a calendar quarter basis beginning on 3/31/18 until final vesting date of 12/31/2020.
(8)	Stock Options granted at $1.40 calculated on a 5-day volume weighted average price (VWAP) for 5 business days - 12/22/17 and 12/26/17-12/29/17.
(9)	Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on December 31, 2018 and ending on September 30, 2021.
(10)	Stock options were granted at an exercise price of $0.84 per share (the average volume weighted average price (VWAP) for the five business day period ending on the business day prior to the date of grant).
(11)	None.
(12)	Each RSU represents the contingent right to receive either (i) one share of common stock upon vesting of the RSU or (ii) a cash payment in an amount equal to the U.S. dollar equivalent of the market price per unit on the vesting date.

Remarks: Mr. Klein is the company's Interim Chief Financial Officer.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KLEIN KENNETH JOSEPH 11700 KATY FREEWAY SUITE 300 HOUSTON, TX 77079			See Remarks

Signatures
/s/ Kenneth Joseph Klein		10/4/2018
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.